Concepedia

Publication | Open Access

In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET

277

Citations

38

References

2020

Year

Abstract

We were able to measure widespread synaptic loss due to AD using [<sup>11</sup> C]UCB-J PET. Future studies will continue to evaluate the utility of SV2A PET for tracking AD progression and for monitoring potential therapies.

References

YearCitations

Page 1